Pharmacological characterizations of the 'legal high' fluorolintane and isomersEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72019-08-014OAAI
The 1980s: d-AP5, LTP and a Decade of NMDA Receptor DiscoveriesNEUROCHEMICAL RESEARCHIF3.82018-10-0423OAAI
Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemiaMOLECULAR BRAINIF2.92017-08-1813OAAI
Ketamine and phencyclidine: the good, the bad and the unexpectedBRITISH JOURNAL OF PHARMACOLOGYIF7.72015-07-28164OAAI
Group III Metabotropic Glutamate Receptors: Pharmacology, Physiology and Therapeutic PotentialIII组代谢型谷氨酸受体: 药理学，生理学和治疗潜力NEUROCHEMICAL RESEARCHIF3.82014-08-2251PREAI
A novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampusNEUROCHEMISTRY INTERNATIONALIF42012-09-0184PREAI
Differences in kainate receptor involvement in hippocampal mossy fibre long-term potentiation depending on slice orientationNEUROCHEMISTRY INTERNATIONALIF42012-09-0112PREAI
Activation of presynaptic α7 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurones in anaesthetized rats: an in vivo iontophoretic studyBRITISH JOURNAL OF PHARMACOLOGYIF7.72010-02-0913OAAI
A novel, competitive mGlu5 receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slicesBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2972OAAI
TC-2559 excites dopaminergic neurones in the ventral tegmental area by stimulating α4β2-like nicotinic acetylcholine receptors in anaesthetised ratsBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-01-2923OAAI
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptorsNEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCEIF02006-02-0670PREAI
LY503430, a novel α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's diseaseJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82003-08-01109PREAI
A role for Ca2+ stores in kainate receptor-dependent synaptic facilitation and LTP at mossy fiber synapses in the hippocampusNEURONIF152003-07-01183OAAI
(3SR,4ARS,6SR,8ARS)-6-(1H-TETRAZOL-5-YL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID, A NOVEL, COMPETITIVE, SYSTEMICALLY ACTIVE NMDA AND AMPA RECEPTOR ANTAGONISTJOURNAL OF MEDICINAL CHEMISTRYIF6.82002-05-0120PREAI
6-SUBSTITUTED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACIDS AS POTENT AND SELECTIVE CONFORMATIONALLY CONSTRAINED NMDA RECEPTOR ANTAGONISTSJOURNAL OF MEDICINAL CHEMISTRYIF6.82002-05-0145PREAI
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTPNEURONIF152001-11-01186OAAI
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists .1. Effects of stereochemistry, chain length, and chain substitutionJOURNAL OF MEDICINAL CHEMISTRYIF6.81996-05-2445PREAI
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists .2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityJOURNAL OF MEDICINAL CHEMISTRYIF6.81996-05-2438PREAI
THE NEUROPROTECTIVE ACTION OF KETAMINE AND MK-801 AFTER TRANSIENT CEREBRAL-ISCHEMIA IN RATSANESTHESIOLOGYIF9.11988-11-01136OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向